Ontology highlight
ABSTRACT: Background
Drug resistance remains from among the most feared public health threats that commonly challenges tuberculosis treatment success. Since 2010, there have been rapid evolution and advances to second-line anti-tuberculosis treatments (SLD). However, evidence on impacts of these advances on incidence of mortality are scarce and conflicting. Estimating the number of people died from any cause during the follow-up period of SLD as the incidence proportion of all-cause mortality is the most informative way of appraising the drug-resistant tuberculosis treatment outcome. We thus aimed to estimate the pooled incidence of mortality and its predictors among persons receiving the SLD in sub-Saharan Africa.Methods
We systematically identified relevant studies published betwee
SUBMITTER: Edessa D
PROVIDER: S-EPMC8664218 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature